Details of the Drug

General Information of Drug (ID: DMRRHOB)

• Drug Name: MK8242

Indication

Disease Entry	ICD 11	Status	REF
Acute myeloid leukaemia	2A60	Phase 2	[1]
Solid tumour/cancer	2A00-2F9Z	Phase 1	[2]

• Cross-matching ID:
  PubChem CID: 52914022
  TTD ID: D0NT6P
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT01463696) Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650). U.S. National Institutes of Health.
• [2] Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.Nat Rev Drug Discov. 2016 Aug;15(8):533-50.